Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants
Yanyun Du, Rui Shi, Ying Zhang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses
Yanjia Chen, Xiaoyu Zhao, Hao Zhou, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 189-199
Open Access | Times Cited: 284
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 118
Close relatives of MERS-CoV in bats use ACE2 as their functional receptors
Qing Xiong, Lei Cao, Chengbao Ma, et al.
Nature (2022) Vol. 612, Iss. 7941, pp. 748-757
Open Access | Times Cited: 106
Bat-infecting merbecovirus HKU5-CoV lineage 2 can use human ACE2 as a cell entry receptor
Jing Chen, Wei Zhang, Yang Li, et al.
Cell (2025)
Closed Access | Times Cited: 9
Multiple independent acquisitions of ACE2 usage in MERS-related coronaviruses
Chengbao Ma, Chen Liu, Young‐Jun Park, et al.
Cell (2025)
Open Access | Times Cited: 6
Net-Shaped DNA Nanostructures Designed for Rapid/Sensitive Detection and Potential Inhibition of the SARS-CoV-2 Virus
Neha Chauhan, Yanyu Xiong, Shaokang Ren, et al.
Journal of the American Chemical Society (2022) Vol. 145, Iss. 37, pp. 20214-20228
Open Access | Times Cited: 67
Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
Jialing Yin, Chengcheng Li, Chunhong Ye, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 824-837
Open Access | Times Cited: 65
Structures of Omicron spike complexes and implications for neutralizing antibody development
Hangtian Guo, Gao Yan, Tinghan Li, et al.
Cell Reports (2022) Vol. 39, Iss. 5, pp. 110770-110770
Open Access | Times Cited: 62
PCIF1-mediated deposition of 5′-cap N 6 ,2′- O -dimethyladenosine in ACE2 and TMPRSS2 mRNA regulates susceptibility to SARS-CoV-2 infection
Lingling Wang, Shaobo Wang, Lujing Wu, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 5
Open Access | Times Cited: 25
Inhalation of ACE2-expressing lung exosomes provides prophylactic protection against SARS-CoV-2
Zhenzhen Wang, Shiqi Hu, Kristen D. Popowski, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
ACE2 utilization of HKU25 clade MERS-related coronaviruses with broad geographic distribution
Chen Liu, Young‐Jun Park, Chengbao Ma, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
Development of SARS-CoV-2 entry antivirals
Meiyue Dong, Jazmin Galván Achi, Ruikun Du, et al.
Cell Insight (2024) Vol. 3, Iss. 1, pp. 100144-100144
Open Access | Times Cited: 8
Design of customized coronavirus receptors
Peng Liu, Meiling Huang, Hua Guo, et al.
Nature (2024) Vol. 635, Iss. 8040, pp. 978-986
Closed Access | Times Cited: 7
Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?
Jingjing Zhang, Han Zhang, Litao Sun
mAbs (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 23
ACE2-using merbecoviruses: Further evidence of convergent evolution of ACE2 recognition by NeoCoV and other MERS-CoV related viruses
Qing Xiong, Chengbao Ma, Chen Liu, et al.
Cell Insight (2024) Vol. 3, Iss. 1, pp. 100145-100145
Open Access | Times Cited: 6
SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies
Hailong Guo, Sha Ha, Jason Botten, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 697-697
Open Access | Times Cited: 6
Sarbecovirus RBD indels and specific residues dictating multi-species ACE2 adaptiveness
Jun-Yu Si, Yuanmei Chen, Ye-Hui Sun, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodies
Fengwen Zhang, Jesse Jenkins, Robson Amparo de Carvalho, et al.
Nature Microbiology (2023) Vol. 8, Iss. 6, pp. 1051-1063
Open Access | Times Cited: 12
Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodies
Guo Du, Huaichuan Duan, Yan Cheng, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 18
Roles of the ACE/Ang II/AT1R pathway, cytokine release, and alteration of tight junctions in COVID-19 pathogenesis
Laith Ashour
Tissue Barriers (2022) Vol. 11, Iss. 2
Open Access | Times Cited: 18
Simultaneous Blockade of CD209 and CD209L by Monoclonal Antibody Does Not Provide Sufficient Protection Against Multiple Viral Infections In Vivo
Yanyun Du, Jiawang Gao, Mengjiao He, et al.
Immunology (2025)
Closed Access
Leveraging mobility data to analyze persistent SARS-CoV-2 mutations and inform targeted genomic surveillance
Riccardo Spott, Mathias W. Pletz, Carolin Fleischmann-Struzek, et al.
eLife (2025) Vol. 13
Open Access
A Structural Voyage Toward the Landscape of Humoral and Cellular Immune Escapes of SARS‐CoV‐2
Jun Liu, Yan Wu, George F. Gao
Immunological Reviews (2025) Vol. 330, Iss. 1
Closed Access
Design and Characterization of Bispecific and Trispecific Antibodies Targeting SARS-CoV-2
Jiayang Wang, Qi Qian, Yushan Jiang, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 255-255
Open Access
Close relatives of MERS-CoV in bats use ACE2 as their functional receptors
Qing Xiong, Lei Cao, Chengbao Ma, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top